Jeffrey H. Newcorn, MD

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York

  • 15Articles
  • 109KReads
  • 2007–2025Active
  • 46Collaborators
  • 124Citations

About

Jeffrey H. Newcorn, MD, is affiliated with the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York. His publications from 2007 to 2025 focus on neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder (ADHD) across child, adolescent, and adult populations. His work addresses clinical assessment methods, treatment strategies including pharmacotherapy, and the management of ADHD with comorbid conditions. He has frequently collaborated with researchers such as Lenard A. Adler and Russell A. Barkley.

Publications

JCP
Validity of an Online ADHD Assessment in a Real-World Sample of Adults Seeking Web-Based Mental Healthcare
Original Research

Validity of an Online ADHD Assessment in a Real-World Sample of Adults Seeking Web-Based Mental Healthcare

September 8, 2025

The online assessment correctly identified over 80% of ADHD-positive cases. Compared with the clinical interview, the online assessment was more conservative in rendering ADHD-positive diagnoses.
, , , et al
JCP
Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study
Original Research

Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study

October 16, 2024

This study demonstrates that ADHD fluctuations are common and substantive and that, when remitted, individuals with fluctuating ADHD can successfully manage increased responsibilities.
, , , et al
JCP
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
Educational Activity

Emerging Therapies for Attention-Deficit/Hyperactivity Disorder

August 9, 2023

While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory...
JCP
Original Research

Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
, , , et al
JCP
Original Research

Atomoxetine Tolerability in Pediatric and Adult Patients Receiving Different Dosing Strategies

December 15, 2013

, , , et al
JCP
Original Research

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety, and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder

December 15, 2012

, , , et al
JCP
Educational Activity

Administering and Evaluating the Results of the Adult ADHD Self-Report Scale (ASRS) in Adolescents

June 15, 2011

,
JCP
Educational Activity

Assessing Adolescents Using ADHD Rating Scales

May 15, 2011

,
JCP
Educational Activity

Performance Improvement CME: Adult ADHD

April 15, 2011

, ,
JCP
Educational Activity

Risks and Benefits of Available Treatments for Adult ADHD

March 15, 2011

PCC
Academic Highlights

Assessing Adults With ADHD and Comorbidities

February 16, 2009

,
JCP
Educational Activity

Managing ADHD and Comorbidities in Adults

February 16, 2009

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe